• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深度学习在利用超声预测乳腺导管原位癌低估方面的应用。

Application of deep learning to predict underestimation in ductal carcinoma in situ of the breast with ultrasound.

作者信息

Qian Lang, Lv Zhikun, Zhang Kai, Wang Kun, Zhu Qian, Zhou Shichong, Chang Cai, Tian Jie

机构信息

Department of Ultrasonography, Fudan University Shanghai Cancer Center, Shanghai, China.

Department of Oncology, Fudan University, Shanghai Medical College, Shanghai, China.

出版信息

Ann Transl Med. 2021 Feb;9(4):295. doi: 10.21037/atm-20-3981.

DOI:10.21037/atm-20-3981
PMID:33708922
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7944276/
Abstract

BACKGROUND

To develop an ultrasound-based deep learning model to predict postoperative upgrading of pure ductal carcinoma in situ (DCIS) diagnosed by core needle biopsy (CNB) before surgery.

METHODS

Of the 360 patients with DCIS diagnosed by CNB and identified retrospectively, 180 had lesions upstaged to ductal carcinoma in situ with microinvasion (DCISM) or invasive ductal carcinoma (IDC) postoperatively. Ultrasound images obtained from the hospital database were divided into a training set (n=240) and validation set (n=120), with a ratio of 2:1 in chronological order. Four deep learning models, based on the ResNet and VggNet structures, were established to classify the ultrasound images into postoperative upgrade and pure DCIS. We obtained the area under the receiver operating characteristic curve (AUROC), specificity, sensitivity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) to estimate the performance of the predictive models. The robustness of the models was evaluated by a 3-fold cross-validation.

RESULTS

Clinical features were not significantly different between the training set and the test set (P value >0.05). The area under the receiver operating characteristic curve of our models ranged from 0.724 to 0.804. The sensitivity, specificity, and accuracy of the optimal model were 0.733, 0.750, and 0.742, respectively. The three-fold cross-validation results showed that the model was very robust.

CONCLUSIONS

The ultrasound-based deep learning prediction model is effective in predicting DCIS that will be upgraded postoperatively.

摘要

背景

开发一种基于超声的深度学习模型,以预测术前经粗针穿刺活检(CNB)诊断的纯导管原位癌(DCIS)术后的病理升级情况。

方法

回顾性纳入360例经CNB诊断为DCIS的患者,其中180例术后病理升级为伴有微浸润的导管原位癌(DCISM)或浸润性导管癌(IDC)。从医院数据库获取的超声图像按时间顺序以2:1的比例分为训练集(n = 240)和验证集(n = 120)。基于ResNet和VggNet结构建立了四个深度学习模型,将超声图像分类为术后升级和纯DCIS。我们通过计算受试者操作特征曲线下面积(AUROC)、特异性、敏感性、准确性、阳性预测值(PPV)和阴性预测值(NPV)来评估预测模型的性能。通过3折交叉验证评估模型的稳健性。

结果

训练集和测试集的临床特征无显著差异(P值>0.05)。我们模型的受试者操作特征曲线下面积在0.724至0.804之间。最佳模型的敏感性、特异性和准确性分别为0.733、0.750和0.742。3折交叉验证结果表明该模型非常稳健。

结论

基于超声的深度学习预测模型在预测术后会发生病理升级的DCIS方面是有效的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a91c/7944276/93c357a28524/atm-09-04-295-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a91c/7944276/58c53d25c5bb/atm-09-04-295-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a91c/7944276/c34ce39914cb/atm-09-04-295-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a91c/7944276/0e1b5f8b4cc8/atm-09-04-295-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a91c/7944276/93c357a28524/atm-09-04-295-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a91c/7944276/58c53d25c5bb/atm-09-04-295-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a91c/7944276/c34ce39914cb/atm-09-04-295-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a91c/7944276/0e1b5f8b4cc8/atm-09-04-295-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a91c/7944276/93c357a28524/atm-09-04-295-f4.jpg

相似文献

1
Application of deep learning to predict underestimation in ductal carcinoma in situ of the breast with ultrasound.深度学习在利用超声预测乳腺导管原位癌低估方面的应用。
Ann Transl Med. 2021 Feb;9(4):295. doi: 10.21037/atm-20-3981.
2
Application of deep learning to identify ductal carcinoma and microinvasion of the breast using ultrasound imaging.深度学习在利用超声成像识别乳腺导管癌及微浸润中的应用。
Quant Imaging Med Surg. 2022 Sep;12(9):4633-4646. doi: 10.21037/qims-22-46.
3
Predicting Underestimation of Invasive Cancer in Patients with Core-Needle-Biopsy-Diagnosed Ductal Carcinoma In Situ Using Deep Learning Algorithms.利用深度学习算法预测核心针活检诊断为导管原位癌患者的浸润性癌低估。
Tomography. 2022 Dec 20;9(1):1-11. doi: 10.3390/tomography9010001.
4
Sonography-based multimodal information platform for identifying the surgical pathology of ductal carcinoma in situ.基于超声的多模态信息平台,用于识别导管原位癌的手术病理。
Comput Methods Programs Biomed. 2024 Mar;245:108039. doi: 10.1016/j.cmpb.2024.108039. Epub 2024 Jan 20.
5
Prediction of the histologic upgrade of ductal carcinoma using a combined radiomics and machine learning approach based on breast dynamic contrast-enhanced magnetic resonance imaging.基于乳腺动态对比增强磁共振成像,采用联合放射组学和机器学习方法预测导管癌的组织学升级。
Front Oncol. 2022 Nov 2;12:1032809. doi: 10.3389/fonc.2022.1032809. eCollection 2022.
6
Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: preoperative predictors of invasive breast cancer.超声引导下14G粗针穿刺活检诊断为乳腺原位导管癌的乳腺肿块:浸润性乳腺癌的术前预测因素
Eur J Radiol. 2014 Apr;83(4):654-9. doi: 10.1016/j.ejrad.2014.01.010. Epub 2014 Jan 20.
7
Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.导管原位癌粗针活检诊断后残留浸润性疾病的预测因素。
Breast J. 2007 May-Jun;13(3):251-7. doi: 10.1111/j.1524-4741.2007.00418.x.
8
Factors associated with upstaging in patients preoperatively diagnosed with ductal carcinoma by core needle biopsy.术前经粗针穿刺活检诊断为导管癌的患者中与分期上调相关的因素。
Cancer Biol Med. 2019 May;16(2):312-318. doi: 10.20892/j.issn.2095-3941.2018.0159.
9
Clinical and Imaging Characteristics of Contrast-enhanced Mammography and MRI to Distinguish Microinvasive Carcinoma from Ductal Carcinoma In situ.对比增强乳腺 X 线摄影和 MRI 的临床及影像学特征,以鉴别微浸润癌和导管原位癌。
Acad Radiol. 2024 Nov;31(11):4299-4308. doi: 10.1016/j.acra.2024.04.041. Epub 2024 May 11.
10
Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?粗针活检发现小叶原位癌或非典型小叶增生:是否需要切除活检?
Radiology. 2004 Jun;231(3):813-9. doi: 10.1148/radiol.2313030874. Epub 2004 Apr 22.

引用本文的文献

1
AI-Based Ultrasound Nomogram for Differentiating Invasive from Non-Invasive Breast Cancer Masses.基于人工智能的超声列线图用于鉴别浸润性与非浸润性乳腺癌肿块
Cancers (Basel). 2025 Jul 29;17(15):2497. doi: 10.3390/cancers17152497.
2
Artificial Intelligence in Diagnostic Breast Ultrasound: A Comparative Analysis of Decision Support Among Radiologists With Various Levels of Expertise.诊断性乳腺超声中的人工智能:不同专业水平放射科医生决策支持的比较分析
Eur J Breast Health. 2025 Jan 1;21(1):33-39. doi: 10.4274/ejbh.galenos.2024.2024-9-7.
3
Prospective study of AI-assisted prediction of breast malignancies in physical health examinations: role of off-the-shelf AI software and comparison to radiologist performance.

本文引用的文献

1
Deep learning analysis of breast MRIs for prediction of occult invasive disease in ductal carcinoma in situ.深度学习分析乳腺 MRI 预测导管原位癌中的隐匿性浸润性疾病。
Comput Biol Med. 2019 Dec;115:103498. doi: 10.1016/j.compbiomed.2019.103498. Epub 2019 Oct 16.
2
Characteristics of ultrasonographic images of ductal carcinoma in situ with abnormalities of the ducts.伴有导管异常的原位导管癌超声图像特征
J Med Ultrason (2001). 2020 Jan;47(1):107-115. doi: 10.1007/s10396-019-00981-z. Epub 2019 Oct 26.
3
Potential Role of Convolutional Neural Network Based Algorithm in Patient Selection for DCIS Observation Trials Using a Mammogram Dataset.
人工智能辅助预测身体健康检查中乳腺恶性肿瘤的前瞻性研究:现成人工智能软件的作用及与放射科医生表现的比较
Front Oncol. 2024 May 2;14:1374278. doi: 10.3389/fonc.2024.1374278. eCollection 2024.
4
Artificial Intelligence in Breast Cancer Diagnosis and Personalized Medicine.人工智能在乳腺癌诊断与个性化医疗中的应用
J Breast Cancer. 2023 Oct;26(5):405-435. doi: 10.4048/jbc.2023.26.e45.
5
A deep learning model using convolutional neural networks for caries detection and recognition with endoscopes.一种使用卷积神经网络的深度学习模型,用于通过内窥镜进行龋齿检测和识别。
Ann Transl Med. 2022 Dec;10(24):1369. doi: 10.21037/atm-22-5816.
6
Artificial Intelligence in Breast Ultrasound: From Diagnosis to Prognosis-A Rapid Review.乳腺超声中的人工智能:从诊断到预后——快速综述
Diagnostics (Basel). 2022 Dec 26;13(1):58. doi: 10.3390/diagnostics13010058.
7
A Comparative Study of Multiple Deep Learning Models Based on Multi-Input Resolution for Breast Ultrasound Images.基于多输入分辨率的乳腺超声图像多深度学习模型比较研究
Front Oncol. 2022 Jul 7;12:869421. doi: 10.3389/fonc.2022.869421. eCollection 2022.
卷积神经网络算法在利用乳腺 X 线摄影数据集进行 DCIS 观察试验患者选择中的潜在作用。
Acad Radiol. 2020 Jun;27(6):774-779. doi: 10.1016/j.acra.2019.08.012. Epub 2019 Sep 14.
4
Reliability of preoperative breast biopsies showing ductal carcinoma in situ and implications for non-operative treatment: a cohort study.术前乳腺活检显示导管原位癌的可靠性及其对非手术治疗的影响:一项队列研究。
Breast Cancer Res Treat. 2019 Nov;178(2):409-418. doi: 10.1007/s10549-019-05362-1. Epub 2019 Aug 6.
5
DCIS with Microinvasion: Is It In Situ or Invasive Disease?微浸润性导管原位癌:是原位癌还是浸润性癌?
Ann Surg Oncol. 2019 Oct;26(10):3124-3132. doi: 10.1245/s10434-019-07556-9. Epub 2019 Jul 24.
6
Predictive factors of upstaging DCIS to invasive carcinoma in BCT vs mastectomy.保乳手术与乳房切除术对比,保乳手术中 DCIS 升级为浸润性癌的预测因素。
Am J Surg. 2019 Jun;217(6):1025-1029. doi: 10.1016/j.amjsurg.2018.12.069. Epub 2019 Feb 23.
7
The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).COMET(手术与监测和内分泌治疗比较)试验:一项针对低危导管原位癌(DCIS)的 III 期随机对照临床试验。
BMJ Open. 2019 Mar 12;9(3):e026797. doi: 10.1136/bmjopen-2018-026797.
8
A systematic study of the class imbalance problem in convolutional neural networks.卷积神经网络中类不平衡问题的系统研究。
Neural Netw. 2018 Oct;106:249-259. doi: 10.1016/j.neunet.2018.07.011. Epub 2018 Jul 29.
9
Breast cancer statistics, 2017, racial disparity in mortality by state.乳腺癌统计数据,2017 年,按州划分的死亡率种族差异。
CA Cancer J Clin. 2017 Nov;67(6):439-448. doi: 10.3322/caac.21412. Epub 2017 Oct 3.
10
A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease.验证性列线图预测导管原位癌向浸润性疾病的升级。
Ann Surg Oncol. 2017 Oct;24(10):2915-2924. doi: 10.1245/s10434-017-5927-y. Epub 2017 Aug 1.